2026 Flagship Program Info Session #2 ​​​Thinking about applying for the Perth Biodesign 2026 Flagship program? Wondering if it's right for you? ​​​You'll learn all about the program structure, what's involved, how past cohorts went, tips for the application process and the time commitment. You'll also hear from Biodesign alumni about their experience!

The Future Health Research and Innovation (FHRI) Fund is inviting Western Australian researchers, innovators, clinicians, consumers and members of the public to help shape future Spotlight Program topics. This short survey will help inform the selection of future Spotlight topics. Topics may focus on specific disease areas or broader health system challenges that require innovative, […]

LX is a leading Australian accelerator that provides comprehensive support to ten healthtech startups, including the investment, networks, and resources required to build globally successful companies. LX has accelerated 52 Australian HealthTech startups. We’ve invested in some, helped raise $33M, connected founders with 1,000+ clinicians, executives, founders, and industry leaders, and provided tailored support from […]

Empowering Australian drug discovery MedChem Australia is a national drug discovery initiative that works with the Australian biomedical research community and guides early-stage projects through the critical value creation steps where ‘hits’ are optimised to drug candidates with enhanced commercial value and clinical potential. MedChem Australia provides expert medicinal chemistry & DMPK capability at 80% […]